Trial intelligence / Profile preview

Nicorandil in acute coronary syndrome

IRCT201202189067N1Phase 2Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of nicorandil in acute coronary syndrome (ACS), sponsored by Kermanshah University of Medical Sciences. Started Feb 2012; status: completed.

02

Drugs

nicorandil
03

Conditions

acute coronary syndrome (ACS)

Beyond the preview

Go deeper on IRCT201202189067N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201202189067N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call